• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol Methods. Neutralizing monoclonal antibodies to different clades of Influenza A H5N1 viruses.

Giuseppe

Emeritus
J Virol Methods. 2009 Jan 16. [Epub ahead of print]

Neutralizing monoclonal antibodies to different clades of Influenza A H5N1 viruses.

Oh S, Selleck P, Temperton NJ, Chan PK, Capecchi B, Manavis J, Higgins G, Burrell CJ, Kok T. - Institute of Medical and Veterinary Science, Adelaide, 5000, SA, Australia.

Four IgG(1kappa) monoclonal antibodies (mAbs) against Influenza A/Chicken/Vietnam/8/2004 (H5N1) virus are described.
Three of these showed neutralizing activities against H5N1 strains from clades 1, 2 and 3 using a retroviral pseudotype or live virus microneutralization assay.
In the pseudotype assay, the IC(90) neutralizing titre range was >1600-51,200, and with the microneutralization was 80>/=10,240.
MAb 1C1 showed strong neutralizing activities in both assays.
All four mAbs reacted specifically to the immunogen by immunohistochemical staining and to A/Hong Kong/483/1997 (H5N1) and A/Thailand/1(KAN-1)/2004 (H5N1)-infected MDCK cells by immunofluorescence.
ELISA titrations of the mAbs showed specificity for H5N1 haemagglutinin (HA) and no cross-reactivity to 15 other Influenza A subtypes.
Only mAbs 1C1 and the non-neutralizing 1F7 reacted with HA(1), the cleaved subunit of HA, by Western blot.
These results suggest that the mAbs recognize distinct or overlapping epitopes and will be useful reagents for construction of specific rapid point-of-care assays or for therapeutic use.

PMID: 19152810 [PubMed - as supplied by publisher
-
------
-
 
Back
Top